| Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management S Shyam Sunder, UC Sharma, S Pokharel Signal Transduction and Targeted Therapy 8 (1), 262, 2023 | 112 | 2023 |
| Echocardiographic and cardiac MRI comparison of longitudinal strain and strain rate in cancer patients treated with immune checkpoint inhibitors J Mirza, SS Sunder, B Karthikeyan, S Kattel, S Pokharel, B Quigley, ... Journal of Personalized Medicine 12 (8), 1332, 2022 | 5 | 2022 |
| Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation MR Zafar, A Sharma, SS Sunder, B Karthikeyan, M Nagahama, A Atia, ... Cardio-Oncology 9 (1), 2, 2023 | 2 | 2023 |
| Cardiotoxic profiles of CAR-T therapy and bispecific T-cell engagers in hematological cancers B Karthikeyan, SS Sunder, I Puzanov, SH Olejniczak, S Pokharel, ... Communications Medicine 4 (1), 116, 2024 | | 2024 |
| Tumor Characteristics and Treatment Responsiveness in Pembrolizumab-Treated Non-Small Cell Lung Carcinoma H Li, S Shyam Sunder, K Jatwani, Y Bae, L Deng, Q Liu, GK Dy, ... Cancers 16 (4), 744, 2024 | | 2024 |
| Left Atrial Appendage Volumetric and Functional Assessment Using Cardiac CT-Derived Three-Dimensional Models A Abdelradi, A Atia, M Kalot, S Shyam Sunder, UC Sharma Circulation 148 (Suppl_1), A15625-A15625, 2023 | | 2023 |
| Left Atrial Appendage Volumetric and Functional Assessment Using Cardiac Computed Tomography-Derived Three-Dimensional Models A Abdelradi, A Atia, M Kalot, SS Sunder, UC Sharma American Journal of Cardiology 205, 360-362, 2023 | | 2023 |
| CARDIOVASCULAR SIDE EFFECTS OF TYROSINE KINASE INHIBITORS USED FOR CANCER THERAPY: ANALYSIS OF SAFETY REPORTS FROM THE WORLD HEALTH ORGANIZATION VIGIBASE DATASETS SS Sunder, B Karthikeyan, S Pokharel, SF Fernandez, U Sharma Journal of the American College of Cardiology 79 (9_Supplement), 1922-1922, 2022 | | 2022 |
